Cannabis stocks rally as Trump reportedly weighs rescheduling
Aug. 11, 2025 6:55 AM ET
By: Dulan Lokuwithana, SA News Editor
Shares of Canadian cannabis companies climbed in the premarket trading on Monday after The Wall Street Journal reported that President Donald Trump is considering whether to reschedule marijuana as a less dangerous drug under the Controlled Substances Act.
At a $1M-a-plate fundraiser event at his New Jersey golf club attended by top industry executives, including Kim Rivers, CEO of Trulieve Cannabis ( OTCQX:TCNNF), earlier this month, Trump said that he is interested in the change, the publication reported, citing people familiar with the matter.
Canadian LPs Canopy Growth (NASDAQ: CGC), Tilray (NASDAQ: TLRY), Cronos ( CRON), Aurora Cannabis (NASDAQ: ACB), SNDL Inc. (NASDAQ: SNDL), and OrganiGram Holdings ( OGI) are among notable gainers.
Cannabis-related U.S. stocks, such as GrowGeneration ( GRWG). Village Farms International ( VFF), Flora Growth ( FLGC), and WM Technology ( MAPS) are also on the rise.
Stocks to watch include U.S. MSOs, Curaleaf Holdings ( OTCPK:CURLF), Acreage Holdings (ACRHF), Cresco Labs ( OTCQX:CRLBF), Green Thumb Industries ( OTCQX:GTBIF), Trulieve Cannabis ( OTCQX:TCNNF), Ayr Wellness ( OTCQX:AYRWF), TerrAscend ( OTCQX:TSNDF) and Verano Holdings ( OTCQX:VRNOF). |
